What is an MCP?
A Model Context Protocol (MCP) is a way of connecting AI agents to external data sources and applications. Rather than manually searching multiple platforms or building complex workflows, an MCP enables AI tools to access relevant information during a conversation and use that information to answer questions, generate analysis and support decision-making.
Beacon’s MCP Connector brings our trusted intelligence directly into your AI agent, allowing your team to access up-to-date pre-clinical, clinical and commercial intelligence through natural language questions.
Why Use Beacon’s MCP Connector?
Connecting Beacon’s expert-curated intelligence directly to your AI enables you to generate reliable, evidence-backed answers without spending a vast amount of time searching, validating and piecing information together.
Less Switching, Less Validating
Move from question to answer without switching between multiple platforms, spreadsheets and sources.
Complete, Trusted Data
Work from curated, complete data that reduces the risk of blind spots in competitive or clinical developments.
Faster Decision-Ready Insights
Generate structured outputs, comparisons and summaries in seconds rather than hours.
Traceable Evidence
Every answer can be linked back to the underlying Beacon records, providing confidence in recommendations and decisions.
Automatically Refreshed Data
Beacon’s intelligence is continually updated, ensuring AI outputs remain accurate and relevant as the landscape evolves.
Natural Language Discovery
Ask questions the way you naturally would, without needing to know where information is stored or how to construct complex searches.
Use Cases
Explore real-world examples of how Beacon MCP accelerates research, strategy and decision-making.
From Disconnected Safety Data to Confident Portfolio Decisions
Beacon MCP enables ADC teams to benchmark HNSTD, compare safety profiles and identify emerging competitive risks directly through their AI agents.
Protocol-Ready Phase I Decisions
Beacon MCP helps CAR-T teams benchmark clinical precedents, evaluate competitive landscapes faster and strengthen Phase I study design directly through their AI agent.
Benchmark PK and Translation with Confidence
Combine AI efficiency with Beacon’s curated evidence to compare exposure, toxicity and clinical outcomes across programmes.
Frequently Asked Questions
Explore common questions about connecting AI assistants to Beacon’s trusted pharmaceutical intelligence.
What is an MCP?
A Model Context Protocol (MCP) is a way of connecting AI agents to external data sources and applications.
Rather than manually searching multiple platforms or building complex workflows, an MCP enables AI tools to access relevant information during a conversation and use that information to answer questions, generate analyses and support decision-making.
How is Beacon MCP different from using AI on its own?
AI tools on their own may create blind spots in high-risk decisions with cherry-picked examples and data which can become outdated and require validation.
Beacon MCP gives AI direct access to fresh, trusted, and human-curated intelligence, helping to reduce gaps, improve accuracy and provide traceable evidence behind each answer.
Can I verify where an answer came from?
Yes. Beacon MCP enables you to trace outputs back to the underlying Beacon data, providing greater transparency and confidence in the information being used to support decisions.
Is Beacon MCP secure?
Yes, Beacon MCP is extremely secure. It only provides access to the Beacon content and permissions that your organisation is authorised to use, enabling teams to work within their existing access controls while bringing curated intelligence into approved AI environments.
Which AI tools can Beacon MCP connect to?
Beacon MCP is designed to work with all AI platforms that support MCP integrations, including ChatGPT, Claude, Microsoft Copilot, Gemini and your internal AI environments.
What Beacon data can my AI access?
The intelligence you can access via Beacon’s MCP depends on your Beacon subscription, but will include programme data, clinical trials, modality specific data for drugs in your competitor’s pipeline, and commercial data within the industry such as deals or acquisitions, for example.
Empower Your Drug Development with Cutting-Edge Data Solutions
ADC
Autoimmune
Bispecific
Cancer Vaccine
Cell Therapy
Checkpoint
CVRM
Cytokine
DDR
Gene Therapy
Microbiome
Neurology
Neuroscience
Oncology
Oncolytic Viruses
Psychiatric
RNA
TPD
Beacon ADC
Complete transparency into the ADC drug development landscape
- Unrivalled comprehensive & accurate preclinical & clinical ADC drug, trial and commercial data
- Access to 4,400+ Drugs, 5,200+ Trials, 2,700+ Companies, and 3,900+ Deals in the ADC space
- Market leading ontologies, enabling precise navigation of specific ADC technologies
- Manually curated by ADC scientists, with data updated daily
Beacon Autoimmune
Complete transparency into the Autoimmune drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Autoimmune drug, trial and commercial data
- Access to 7,900+ Drugs, 15,500+ Trials, 7,700+ Companies, and 12,500+ Deals in the Autoimmune space
- Market leading ontologies, enabling precise navigation of specific Autoimmune therapies
- Manually curated by Autoimmune scientists, with data updated daily
Beacon Bispecific
Complete transparency into the Bispecific drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Bispecific therapeutic drug, trial and commercial data
- Access to 4,000+ Drugs, 4,000+ Trials, 2,500+ Companies, and 3,700+ Deals in the Bispecific space
- Market leading ontologies, enabling precise navigation of specific Bispecifics
- Manually curated by Bispecific scientists, with data updated daily
Beacon Cancer Vaccine
Complete transparency into the Cancer Vaccine development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cancer Vaccine drug, trial and commercial data
- Access to 1,900+ Drugs, 1,900+ Trials, 1,700+ Companies, and 2,200+ Deals in the Cancer Vaccine space
- Market leading ontologies, enabling precise navigation of specific Cancer Vaccines
- Manually curated by Cancer Vaccine scientists, with data updated daily
Beacon Cell Therapy
Complete transparency into the Cell Therapy development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cell Therapy drug, trial and commercial data
- Access to 8,800+ Drugs, 7,200+ Trials, 3,900+ Companies, and 5,900+ Deals in the Cell Therapy space
- Market leading ontologies, enabling precise navigation of specific Cell Therapies
- Manually curated by Cell Therapy scientists, with data updated daily
Beacon Checkpoint
Complete transparency into the Checkpoint drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Checkpoint drug, trial and commercial data
- Access to 2,700+ Drugs, 18,200+ Trials, 2,600+ Companies, and 4,100+ Deals in the Checkpoint space
- Market leading ontologies, enabling precise navigation of specific Checkpoint therapeutics
- Manually curated by Checkpoint scientists, with data updated daily
Beacon CVRM
Complete transparency into the CVRM drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical CVRM drug, trial and commercial data
- Access to 5,000+ Drugs, 16,500+ Trials, 4,500+ Companies, and 9,000+ Deals in the CVRM space
- Market leading ontologies, enabling precise navigation of the CVRM drug development landscape
- Manually curated by CVRM scientists, with data updated daily
Beacon Cytokine
Complete transparency into the Cytokine drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cytokine drug, trial and commercial data
- Access to 3,800+ Drugs, 11,900+ Trials, 3,800+ Companies, and 5,600+ Deals in the Cytokine space
- Market leading ontologies, enabling precise navigation of specific Cytokine targeting therapies
- Manually curated by Cytokine scientists, with data updated daily
Beacon DDR
Complete transparency into the DDR drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical DDR drug, trial and commercial data
- Access to 900+ Drugs, 2,200+ Trials, 1,200+ Companies, and 1,400+ Deals in the DDR space
- Market leading ontologies, enabling precise navigation of the DDR drug development landscape
- Manually curated by DDR scientists, with data updated daily
Beacon Gene Therapy
Complete transparency into the Gene Therapy drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Gene Therapy drug, trial and commercial data
- Access to 2,900+ Drugs, 1,400+ Trials, 2,100+ Companies, and 3,200+ Deals in the Gene Therapy space
- Market leading ontologies, enabling precise navigation of specific Gene Therapies
- Manually curated by Gene Therapy scientists, with data updated daily
Beacon Microbiome
Complete transparency into the Microbiome drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Microbiome drug, trial and commercial data
- Access to 1,400+ Drugs, 1,400+ Trials, 1,100+ Companies, and 1,200+ Deals in the Microbiome space
- Market leading ontologies, enabling precise navigation of the Microbiome drug development landscape
- Manually curated by Microbiome scientists, with data updated daily
Beacon Neurology
Complete transparency into the Neurology drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Neurology drug, trial and commercial data
- Access to 8,700+ Drugs and 10,300+ Trials, 5,900+ Companies, and 13,200+ Deals in the Neurology space since 2011
- Market leading ontologies, enabling precise navigation of the Neurology drug development landscape
- Manually curated by Neurology scientists, with data updated daily
Beacon Neuroscience
Complete transparency into the Neuroscience drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Neuroscience drug, trial and commercial data
- Access to 9,900+ Drugs, 14,400+ Trials, 6,400+ Companies, and 14,200+ Deals in the Neuroscience space since 2011
- Market leading ontologies, enabling precise navigation of the Neuroscience drug development landscape
- Manually curated by Neuroscience scientists, with data updated daily
Beacon Oncology
Complete transparency into the Oncology drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Oncology drug, trial and commercial data
- Access to 30,500+ Drugs, 58,400+ Trials, 10,300+ Companies, and 19,900+ Deals in the Oncology space
- Market leading ontologies, enabling precise navigation of the Oncology drug development landscape
- Manually curated by Oncology scientists, with data updated daily
Beacon Oncolytic Viruses
Complete transparency into the Oncolytic Viruses drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Oncolytic Virus drug, trial and commercial data
- Access to 800+ Drugs, 700+ Trials, 600+ Companies, and 700+ Deals in the Oncolytic Virus space
- Market leading ontologies, enabling precise navigation of specific Oncolytic Virus’
- Manually curated by Oncolytic Virus scientists, with data updated daily
Beacon Psychiatric
Complete transparency into the Psychiatric drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Psychiatric drug and trial data
- Access to 1,800+ Drugs, 4,500+ Trials, 1,400+ Companies, and 3,600+ Deals in the Psychiatric space since 2011
- Market leading ontologies, enabling precise navigation of the Psychiatric drug development landscape
- Manually curated by Psychiatric scientists, with data updated daily
Beacon RNA
Complete transparency into the RNA drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical RNA therapeutic drug, trial and commercial data
- Access to 6,500+ Drugs, 3,100+ Trials, 3,700+ Companies, and 5,500+ Deals in the RNA Therapeutic space
- Market leading ontologies, enabling precise navigation of specific RNA therapeutics
- Manually curated by RNA scientists, with data updated daily
Beacon TPD
Complete transparency into the TPD drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical TPD drug, trial and commercial data
- Access to 2,700+ Drugs, 4,800+ Trials, 1,700+ Companies, and 2,000+ Deals in the TPD space
- Market leading ontologies, enabling precise navigation of the TPD drug development landscape
- Manually curated by TPD scientists, with data updated daily
Additional Resources
Check out additional resources available from Beacon
About Beacon
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
See how our clinical trials and drug database solutions in action.
Search